You
now have the opportunity to read the first multicenter clinical study
carried out in several Latin American countries that clearly
demonstrates that chlorine dioxide is a fully effective treatment
against COVID-19.
The
study was registered and accepted in clinicaltrials.gov on April 7,
2020 (NCT 04343742) and falls within the studies categorized as ECE
(quasi-experimental studies) by the NCBI (National Center for
Biotechnology Information).
This is the first clinical studywith chlorine dioxide for therapeutic use in humans, demonstrating with scientific evidence its effectiveness and safety in the treatment for COVID-19. The research focused on studying the effectiveness of the use of ClO2 in patients with SARS-CoV-2,
measuring before and after treatment, the clinical symptoms present and
laboratory variables based on standardized and accepted scales in
research (VAS and Likert) of an experimental group, compared to a
control group.
A hope to end the COVID-19 pandemic
The
clinical study showed that chlorine dioxide is effective in patients
treated with oral ClO2 and that its use in the COVID-19 pandemic becomes
and positions itself as a great hope to control it, based on the
scientific foundations revealed in previous research .
Chlorine
dioxide was shown to be beneficial in the treatment of COVID-19, making
negative RT-PCR at 7 days in one hundred percent of the patients who
took it during the clinical study, rapidly mitigating their symptoms
associated with this disease, and significantly reducing the laboratory
parameters to normal in a space of 14 to 21 days.
In
addition, the researchers observed that patients who consumed chlorine
dioxide as a treatment for COVID-19 also substantially reduced
post-illness symptoms, compared to patients not treated with ClO2.
We are facing a solution that can end the pandemic, now scientifically proven: CDS works and saves lives!
Following
this clinical study, physicians around the world now have the right to
legally use chlorine dioxide in accordance with the
paragraph 37 of the Declaration of Helsinki *. The therapeutic use of chlorine dioxide gives new hope to end the COVID-19 pandemic and save millions of lives.
The
Declaration of Helsinki has been promulgated by the World Medical
Association as a body of ethical principles that should guide the
medical community, and paragraph 37 states the following:
“When
proven interventions do not exist in the care of a patient or other
known interventions have been ineffective, the physician, after seeking
expert advice, with the informed consent of the patient or an authorized
legal representative, may be allowed to use unproven interventions ,
if, in his opinion, this gives some hope of saving life, restoring
health or alleviating suffering. Such interventions should be further
investigated in order to assess their safety and efficacy. In all cases,
this new information must be recorded and, when appropriate, made
available to the public. "
Chlorine dioxide is approved by law in Bolivia
In
Bolivia, Law No. 1351 of 2020 was approved that authorized the
preparation, commercialization, supply and use under consent of the CDS
chlorine dioxide solution, as prevention and treatment in the face of
the COVID-19 pandemic. An ethics committee was legally constituted
endorsed by the Bolivian Ministry of Health, which approved this
multicenter, retrospective, international research protocol, made up of
five universities (Technical University of Oruro, Public University of
El Alto, Greater University of San Simón , Universidad Autónoma Gabriel
René Moreno and the Technical Institute of Yacuiba "Gran Chaco") which
in turn, through their clinical, scientific and ethical research
committees, are conducting their own research on chlorine dioxide for
use in different Applications.
Statistics
from Bolivia show a marked reduction in cases and deaths in that
country. For example, from a peak of 2031 daily cases on August 20,
2020, cases dropped to 147 daily cases on October 21, 2020, representing
a 93% decrease.
While in
other countries the increase in mortality was maintained, in Bolivia it
fell, attributing this decrease to the consumption of chlorine dioxide
as a possible explanation.
In
other Latin American countries, chlorine dioxide is also beginning to be
used with great success to combat COVID-19, as, for example, do the
doctors who make up the
COMUSAV, World Health and Life Coalition (
www.comusav.com) who apply it to their patients with excellent results.
Therapeutic action of chlorine dioxide
The
therapeutic action of chlorine dioxide against COVID-19 is given by its
selectivity for pH and viral size. This means that the ClO2
it dissociates and releases oxygen when it comes into contact with the
virus. When it dissociates, it oxidizes the present spikes of acidic pH
and becomes sodium chloride (common salt) and at the same time releases
molecular oxygen O2, which in turn helps local cell recovery.
Therefore, when chlorine dioxide dissociates, it releases oxygen just
like erythrocytes (red blood cells) through the same principle, which is
to be selective for acidity (Bohr effect). Chlorine dioxide releases
molecular oxygen when it encounters an acidic environment, either
through histamine or the acidity of the virus itself. The ClO2 is an antimicrobial agent whose action is selective by size and therefore It does not affect human cells due to its large size compared to the virus and it is extremely effective on all types of viruses including COVID-19 with all its variants and strains.
Multicellular
tissue has the ability to dissipate this charge and is therefore not
affected. A great advantage of the therapeutic use of ClO2, is the impossibility of a viral resistance.
It is the first scientific study in humans with chlorine dioxide for therapeutic use that indicates clear efficacy that must be investigated without fail, with larger studies to save many thousands of lives.
This
exceptional study has been registered and accepted in
clinicaltrials.gov on April 7, 2020 (NCT 04343742) and falls within the
studies categorized as ECE (quasi-experimental pilot studies) by the
NCBI (National Center for Biotechnology Information).
If you want to access this pioneering study and expand your knowledge about it, you can download it from the following link.
